ATP5MK and breast cancer: This approach suggested that AGP-HA NPs could inhibit tumor migration by dampening inflammation, leading to the resensitization of MDR cells (MDA-MB-231) to the chemotherapeutic drug (DOX) via enhancing DOX lethality towards drug-resistance breast cancer cells.